VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Postoperative flurbiprofen axetil
Phase 3
Small molecule
C
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Perioperative Analgesia
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Perioperative Analgesia
Phase 3
Recruiting
Clinical
Trials by Indication
[1]
Perioperative Analgesia
1 trial
Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
Recruiting
·
—
·
Phase 2/3
·
NCT05504265
·
102 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Postoperative flurbiprofen axetil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Postoperative flurbiprofen axetil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Postoperative flurbiprofen axetil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Cancer Institute and Hospital, Chinese Academy of Medical Sciences company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 3
[1]
Company
C
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Related News